Lori Herndon, who began her career at AtlantiCare more than three decades ago as a nurse, will succeed David Tilton as president and CEO of the New Jersey subsidiary of Geisinger Health System.
When Salt Lake City residents search the Web for physician reviews, they're likely to come across a set of ratings from an unlikely source: the University of Utah Health Care's website. But in the three years since UUHC moved to systemwide public reviews, measures of patient satisfaction have...
Big insurance mergers, the evolution of the nation's delivery systems, the direction of drug and device regulation—these are some of the more important issues we'll be covering this year, and they drove our decisions on which people to watch in 2016.
Geisinger Health System is benefiting from acquisitions and a focus on high-acuity service lines, but the group still saw its expenses outpace revenue in its fiscal first quarter.
HHS' partnership this month with OptumLabs is likely to add momentum to the push to use big data to lower healthcare costs and improve the quality of care delivery.
In 2010, Humana shelled out nearly $800 million for occupational and urgent-care provider Concentra, starting a small wave of insurers buying providers. But it turns out insurers are more interested in striking new types of contracts with providers than owning them.
New York's experiment to better coordinate care for low-income and disabled state residents who are dually eligible for Medicaid and Medicare is losing hundreds of beneficiaries.
Diabetic patients are a popular target population for health systems that hope to improve patients' health with better care coordination and closer management. But new data from the research collaborative OptumLabs suggest diabetes management can be too aggressive.
After a strong increase in net patient revenue, Geisinger Health System reported an operating margin of 3.5% for fiscal 2015, a slight uptick compared with 3.4% last year.
Dr. David Feinberg, who succeeded Dr. Glenn Steele as president and CEO of Geisinger Health System, discusses his system's genetic research program, the challenges of managing the health of Medicaid patients and how he plans to make Geisinger more patient-centered.
The Affordable Care Act's experiments in Medicare payment reform have their doubters, but investors see opportunity. Several companies have emerged to capitalize on the ACA's complex new programs designed to change how traditional Medicare spends more than $450 billion a year in payments.
Healthcare is an economic paradox. On one hand, it's our nation's fastest-growing employer, projected to add 15.6 million jobs by 2022. On the other, high costs coupled with an aging population are breaking budgets.